Hebei Veyong pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang City, Hebei Province, China. It is a large veterinary enterprise with GMP certificate in China with research and development, production and sales of veterinary APIs and preparations. It has been awarded as National High and New-Technology Enterprise, Hebei Provincial Excellent Scientific and Technological Innovation Enterprise, Enterprise with Most Influential Brand in Animal Husbandry, Excellent Enterprise Technology Center, and Scientific and Technology Little Giant Enterprise, and so on.For APIs, in Shijiazhuang production base, Veyong has 6 API production lineswith the main products: Ivermectin, Eprinomectin, Tiamulin Fumarate, Valnemulin HCl, Oxytetracycline HCl, Closantel Sodium etc; in the production base of Ordos in Inner Mongolia , the main product is Abamectin. In additional, Veyong has 10 preparations production lines, including: injection, oral solution, powder-injection, tablet, granules, powder, premix, pesticides for external use, disinfectant etc. The total preparation products with different specifications are more than 160. The company has 4 national new veterinary drugs and several invention patents.Veyong obtained the ISO9001, ISO14001 and OHSAS18001 certificates; obtained the GMP certificate for the first time in 2005, and the GMP certificate for the new plant in November, 2014; obtained COS certificate of Ivermectin in September, 2009 and the update COS certificate in Oct, 2014; accepted the on-site inspection from US FDA in August, 2018. Veyong has established a marketing channel covering the whole country and a sales network serving the end customers in China. Relying on the superiority of Ivermectin,Veyong has made a long term cooperation with many internationally known pharmaceutical enterprises with products sold to more than 50 countries and areas all over the world.